Salud y calidad de vida de personas mayores con demencia institucionalizadas

La demencia en personas mayores puede tener muchas causas, entre ellas la enfermedad de Alzheimer. Independientemente de su causa, las personas mayores con demencia ven su vida afectada de muchas formas, con una pérdida gradual de su autonomía, incremento de los problemas de salud y necesidad creciente de cuidados; todo esto se refleja en un detrimento de su calidad de vida. Es importante profundizar en las características de las personas mayores con demencia institucionalizadas, para de esta forma conocer mejor sus necesidades, y así poder desarrollar intervenciones que mantengan y mejoren su calidad de vida. Este libro describe los resultados de un estudio desarrollado por un equipo de investigación multidisciplinar, con la participación de profesionales de las siguientes áreas de conocimiento: enfermería, estadística, geografía, geriatría, medicina preventiva, neurología y neuropsicología, psicología y sociología

Rasch analysis of the living with chronic illness scale in Parkinson's disease

Background Neurologists play an essential role in facilitating the patient's process of living with Parkinson's disease (PD). The Living with Chronic Illness Scale-PD (LW-CI-PD) is a unique available clinical tool that evaluates how the patient is living with PD. The objective of the study was to analyse the LW-CI-PD properties according to the Rasch model. Methods An open, international, cross-sectional study was carried out in 324 patients with Parkinson's disease from four Latin American countries and Spain. Psychometric properties of the LW-CI-PD were tested using Rasch analysis: fit to the Rasch model, item local independency, unidimensionality, reliability, and differential item functioning by age and gender. Results Original LW-CI-PD do not fit Rasch model. Modifications emerged included simplifying the response scale and deleting misfit items, the dimensions Acceptance, Coping and Integration showed a satisfactory fit to the Rasch model, with reliability indices greater than 0.70. The dimensions Self-management and Adjustment to the disease did not reach fit to the Rasch model. Conclusion Suggestions for improving the LW-CI-PD include a multidimensional and shorter scale with 12 items grouped in three subscales with a simpler response scheme. The final LW-CI-PD Scale version is a reliable scale, with good internal construct validity, that provides Rasch transformed results on linear metric scale

A Methodological Approach for Implementing an Integrated Multimorbidity Care Model: Results from the Pre-Implementation Stage of Joint Action CHRODIS-PLUS

Patients with multimorbidity (defined as the co-occurrence of multiple chronic diseases) frequently experience fragmented care, which increases the risk of negative outcomes. A recently proposed Integrated Multimorbidity Care Model aims to overcome many issues related to fragmented care. In the context of Joint Action CHRODIS-PLUS, an implementation methodology was developed for the care model, which is being piloted in five sites. We aim to (1) explain the methodology used to implement the care model and (2) describe how the pilot sites have adapted and applied the proposed methodology. The model is being implemented in Spain (Andalusia and Aragon), Lithuania (Vilnius and Kaunas), and Italy (Rome). Local implementation working groups at each site adapted the model to local needs, goals, and resources using the same methodological steps: (1) Scope analysis; (2) situation analysis-"strengths, weaknesses, opportunities, threats" (SWOT) analysis; (3) development and improvement of implementation methodology; and (4) final development of an action plan. This common implementation strategy shows how care models can be adapted according to local and regional specificities. Analysis of the common key outcome indicators at the post-implementation phase will help to demonstrate the clinical effectiveness, as well as highlight any difficulties in adapting a common Integrated Multimorbidity Care Model in different countries and clinical settings

Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)

BACKGROUND: Worldwide data for cancer survival are scarce. We aimed to initiate worldwide surveillance of cancer survival by central analysis of population-based registry data, as a metric of the effectiveness of health systems, and to inform global policy on cancer control. METHODS: Individual tumour records were submitted by 279 population-based cancer registries in 67 countries for 25·7 million adults (age 15-99 years) and 75,000 children (age 0-14 years) diagnosed with cancer during 1995-2009 and followed up to Dec 31, 2009, or later. We looked at cancers of the stomach, colon, rectum, liver, lung, breast (women), cervix, ovary, and prostate in adults, and adult and childhood leukaemia. Standardised quality control procedures were applied; errors were corrected by the registry concerned. We estimated 5-year net survival, adjusted for background mortality in every country or region by age (single year), sex, and calendar year, and by race or ethnic origin in some countries. Estimates were age-standardised with the International Cancer Survival Standard weights. FINDINGS: 5-year survival from colon, rectal, and breast cancers has increased steadily in most developed countries. For patients diagnosed during 2005-09, survival for colon and rectal cancer reached 60% or more in 22 countries around the world; for breast cancer, 5-year survival rose to 85% or higher in 17 countries worldwide. Liver and lung cancer remain lethal in all nations: for both cancers, 5-year survival is below 20% everywhere in Europe, in the range 15-19% in North America, and as low as 7-9% in Mongolia and Thailand. Striking rises in 5-year survival from prostate cancer have occurred in many countries: survival rose by 10-20% between 1995-99 and 2005-09 in 22 countries in South America, Asia, and Europe, but survival still varies widely around the world, from less than 60% in Bulgaria and Thailand to 95% or more in Brazil, Puerto Rico, and the USA. For cervical cancer, national estimates of 5-year survival range from less than 50% to more than 70%; regional variations are much wider, and improvements between 1995-99 and 2005-09 have generally been slight. For women diagnosed with ovarian cancer in 2005-09, 5-year survival was 40% or higher only in Ecuador, the USA, and 17 countries in Asia and Europe. 5-year survival for stomach cancer in 2005-09 was high (54-58%) in Japan and South Korea, compared with less than 40% in other countries. By contrast, 5-year survival from adult leukaemia in Japan and South Korea (18-23%) is lower than in most other countries. 5-year survival from childhood acute lymphoblastic leukaemia is less than 60% in several countries, but as high as 90% in Canada and four European countries, which suggests major deficiencies in the management of a largely curable disease. INTERPRETATION: International comparison of survival trends reveals very wide differences that are likely to be attributable to differences in access to early diagnosis and optimum treatment. Continuous worldwide surveillance of cancer survival should become an indispensable source of information for cancer patients and researchers and a stimulus for politicians to improve health policy and health-care systems

Salud y calidad de vida de personas mayores con demencia institucionalizadas

La demencia en personas mayores puede tener muchas causas, entre ellas la enfermedad de Alzheimer. Independientemente de su causa, las personas mayores con demencia ven su vida afectada de muchas formas, con una pérdida gradual de su autonomía, incremento de los problemas de salud y necesidad creciente de cuidados; todo esto se refleja en un detrimento de su calidad de vida. Es importante profundizar en las características de las personas mayores con demencia institucionalizadas, para de esta forma conocer mejor sus necesidades, y así poder desarrollar intervenciones que mantengan y mejoren su calidad de vida. Este libro describe los resultados de un estudio desarrollado por un equipo de investigación multidisciplinar, con la participación de profesionales de las siguientes áreas de conocimiento: enfermería, estadística, geografía, geriatría, medicina preventiva, neurología y neuropsicología, psicología y sociología

Psychometric evaluation of the spanish families importance in nursing care: nurses' attitudes scale through classical test theory and rasch analysis

Nurses' attitudes toward families play an important role in improving relationships with patients' families. It is essential to have valid and reliable instruments to assess nurses' attitudes toward involving families. The aim of this study was to analyze the psychometric properties of the refined Spanish version of the Families' Importance in Nursing Care-Nurses' Attitudes (FINC-NA) according to classical test theory and the Rasch model (N = 263). Cronbach's alpha values were .73 to .87 and intraclass correlation coefficients ranged from .72 to .86. Rasch analysis results suggested that it was a multidimensional scale with four dimensions and a simpler response scheme than the original scale. Except for one item, the scale was free from bias regarding age and experience time. The FINC-NA is a reliable and valid measure showing a good fit to the Rasch model and is ready to map nurses' attitudes and measure the effectiveness of family nursing educational interventions

Multimorbidity care model: recommendations from the consensus meeting of the Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS).

Patients with multimorbidity have complex health needs but, due to the current traditional disease-oriented approach, they face a highly fragmented form of care that leads to inefficient, ineffective, andpossibly harmful clinical interventions. There is limited evidence on available integrated and multidi-mensional care pathways for multimorbid patients. An expert consensus meeting was held to develop aframework for care of multimorbid patients that can be applied across Europe, within a project fundedby the European Union; the Joint Action on Chronic Diseases and Promoting Healthy Ageing across theLife Cycle (JA-CHRODIS). The experts included a diverse group representing care providers and patients,and included general practitioners, family medicine physicians, neurologists, geriatricians, internists,cardiologists, endocrinologists, diabetologists, epidemiologists, psychologists, and representatives frompatient organizations. Sixteen components across five domains were identified (Delivery of Care; DecisionSupport; Self Management Support; Information Systems and Technology; and Social and CommunityResources). The description and aim of each component are described in these guidelines, along with asummary of key characteristics and relevance to multimorbid patients. Due to the lack of evidence-basedrecommendations specific to multimorbid patients, this care model needs to be assessed and validatedin different European settings to examine specifically how multimorbid patients will benefit from thiscare model, and whether certain components have more importance than others

Transducer-based evaluation of tremor

10.1002/mds.26671Movement Disorders3191327-1336MOVD